B1. ORIGINAL ARTICLES:
1. P. Bellanger, M. Vogel, M. Kevorkian, B. Belhassen, G. Motte, J.J. Welti: Techniques, indications et resultats de l'entrainement electro-systolique en medecine d'urgence. Experience de l'unite de soins intensifs cardiologiques de l'hopital Fernand Widal. Ann Med Interne (Paris) 125:553-560, 1974.
2. G. Motte, B. Belhassen, M. Vogel, Ph. Bellanger, J.J. Welti: Etude critique des explorations endocavitaires dans le diagnostic des blocs auriculo-ventriculaires aroxystiques.
Ann Cardiol Angeiol (Paris) 24:557-568, 1975.
3. P. Renault, R. Parrot, B. Belhassen, Fr. Carnot: Le depistage systematique des cancers broncho-pulmonaires par l'etude des crachats: Experience pilote sur 300 cas, en milieu sanatorial. Ann Med Interne (Paris) 127:43-46, 1976.
4. P. Bodereau, A. Calibre, M. Kevorkian, B. Belhassen, G. Motte, J.J. Welti: Entrainement electro-systolique permanent et manifestations cliniques de l' insuffisance coronarienne. Ann Med Interne (Paris) 129:711-714, 1978.
5. G. Motte, B. Belhassen, P. Bodereau: Syndrome de Wolff-Parkinson-White patent ou inapparent associe a une dualite de conduction nodale. A propos de 4 observations.
Arch Mal Coeur 72:231-240, 1979.
6. G. Motte, C. Sebag, B. Belhassen, J. Vaysse, J.J. Welti: Les bitachycardies. Arch Mal Coeur 73:336-348, 1980.
7. B. Belhassen, A. Pelleg, E. Ostrzega, S. Laniado: ECG indicators of accessory pathway involvement in paroxysmal supraventricular tachycardia. Isr J Med Sci 16:581-587, 1980.
8. B. Belhassen, B. Vidne, I. Shapira, H. Miller, V. Yakirevich, A. Caspi, A. Pelleg, E. Hochhauser, S. Laniado: Electrophysiological studies in the surgical treatment of ventricular tachyarrhythmias. Harefuah 101:337-342, 1981.
8. ב. בלאסן, ב. וידנה, י. שפירא, ה. מילר, ו. יקירביץ', א. כספי, א. פלג, א. הוכהאוזר, ש. לניאדו: שימוש בבדיקות אלקטרופיסיולוגיות בטיפול כירורגי בהפרעות-קצב חדריות מהירות. הרפואה, כרך ק"א, עמ' 337-341, תשמ"ב.
9. H.I. Miller, I. Shapira, A. Roth, S. Braun, E. Ostrzega, B. Belhassen, S.A. Landes, V. Yakirevitch, B. Vidne, S. Laniado: Intracoronary thrombolysis in acute myocardial infarction. Harefuah 103:41-46, 1982.
9. ה. מילר, י. שפירא, א. רוט, ש. בראון, א. אוסטשגה, ב. בלאסן, ס. א. לנדס, ו. יקירביץ', וידנה, ש. לניאדו: המסת פקק תוך-כללי בשלב החד של אוטם שריר הלב. הרפואה, כרך ק"ג, עמ' 41-46, תשמ"ב.
10. B. Belhassen, I. Shapira, N. Kauli, A. Keren, S. Laniado: Initiation of ventricular tachycardia by supraventricular beats. Cardiology 69:203-213, 1982.
11. ב. בלאסן, י. שפירא, ה. רומנטש, ה. מילר, א. אוסטשגה, ש. בראון, ש. עמיקם, לניאדו: הפרעות ברפוליזציה,בעת הולכה תו-חדרית תקינה אצל חולים עם חסם סירוגי בצרור ההולכה השמאלי. ממצאי בדיקות פולשניות ובלתי-פולשניות אצל עשרה חולים.
הרפואה, כרך ק"ג, עמ', 181-184, תשמ"ג.
11. B. Belhassen, I. Shapira, H.H. Rotmensch, H.I. Miller, E. Ostrzega, S. Braun, S. Amikam, S. Laniado: Repolarization abnormalities during normal conduction in ntermittent left bundle branch block. Harefuah 103:181-184, 1982.
12. A. Chagnac, A. Pelleg, B. Belhassen, J. Lubliner, B. Vidne, S. Laniado: Effects of disopyramide on reperfusion arrhythmias in dogs. J Cardiovasc Pharmacol 4:994-998, 1982.
13. B. Belhassen, I. Shapira, A. Paredes, A. Ashkenazi, A. Pelleg, H.I. Miller, S. Laniado:
Role of electrophysiologic studies in selecting preventive therapy in recurrent sustained ventricular tachycardia. Harefuah 104:4-9, 1983.
13. ב. בלאסן, י. שפירא, א. פרדס, ב. אשכנזי, א. פלג, ה. מילר, ש. לניאדו: תפקיד המבחנים האלקטרופיסיולוגיים בבחירת טיפול אצל חולים עם מהירות חדרית ממושכת חוזרת: דיווח על 22 מקרים.
הרפואה, כרך ק"ד, עמ' 4-9 , תשמ"ג.
14. S. Abboud, B. Belhassen, S. Laniado, D. Sadeh:
Non-invasive recording of late ventricular activity using an advanced method in patients with a damaged mass of ventricular tissue. J Electrocardiology 16:245-252, 1983.
15. S. Abboud, B. Belhassen, A. Pelleg, S. Laniado, D. Sadeh: An advanced non-invasive technique for the recording of His bundle potential in man. J Electrocardiology 16:397-402, 1983.
16. B. Belhassen, A. Pelleg, G. Motte, S. Laniado: Determination of the left bundle branch refractoriness by distal His bundle pacing in patients with left bundle branch block. PACE 6:1245-1251, 1983.
17. B. Belhassen, V. Yakirevich, I. Shapira, H.I. Miller, A. Caspi, A. Pelleg, S. Laniado, B.A. Vidne: Surgical treatment of life-threatening ventricular tachyarrhythmias. Journal of Bloodless Medicine and Surgery 1:32-34, 1983.
18. B. Belhassen, A. Pelleg, D. Shoshani, B. Geva, S. Laniado: Electrophysiologic effects of adenosine-5'-triphosphate (ATP) on atrioventricular reentrant tachycardia. Circulation 68:827-833, 1983.
19. S. Abboud, B. Belhassen, A. Pelleg, S. Laniado, D. Sadeh: Non-invasive recording of His bundle activity in patients with Wolff- Parkinson-White syndrome. PACE 7:40-45, 1984.
20. B. Belhassen, I. Shapira, A. Pelleg, I. Copperman, N. Kauli, S. Laniado:Idiopathic recurrent sustained ventricular tachycardia responsive to verapamil: an ECG-electrophysiologic entity. Am Heart J 108:1034-1037, 1984.
21. H.H. Rotmensch, B. Belhassen, B.N. Swanson, D. Shoshani, S.R. Spielman, A.J. Greenspon, A.M. Greenspan, P.H. Vlasses, L.N. Horowitz: Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity. Ann Intern Med 101:462-469, 1984.
22. G. Keren, B. Belhassen, J. Sherez, H.I. Miller, R. Megidish, D. Berenfeld, S. Laniado: Apical hypertrophic cardiomyopathy: evaluation by noninvasive and invasive techniques in 23 patients. Circulation 71:45-56, 1985.
23. A. Pelleg, B. Belhassen, R. Ilia, S. Laniado: Comparative electrophysiologic effects of adenosine triphosphate and adenosine in the canine heart: influence of atropine, propranolol, vagotomy, dipyridamole and aminophylline. Am J Cardiol 55:571-576, 1985.
24. B. Belhassen, R. Ilia, A. Pelleg, A. Greenspan, L. Horowitz: A comparative study of the electrophysiologic effects of Striadyne, adenosine triphosphate and adenosine in the canine heart. Cardiology 72:113-122, 1985.
25. B. Belhassen, I. Shapira, G. Keren, S. Laniado: Clinical significance of nonclinical ventricular tachycardia induced in amiodarone-treated patients. Eur Heart J 6:266-275, 1985.
26. A. Pelleg, A. Roth, B. Shargordsky, B. Belhassen, A. Chagnac, S. Laniado: Effects of dantrolene sodium on occlusion and reperfusion arrhythmias in the canine heart. Meth and Find Exptl Clin Pharmacol 7:239-243, 1985.
27. A. Pelleg, Y. Pardo, B. Belhassen, B. Shargordsky, A. Chagnac, S. Laniado: The effects of verapamil and bepridil on occlusion and reperfusion arrhythmias in the canine heart. Cardiology 72:193-201, 1985.
28. Y. Eshchar, B. Belhassen, S. Laniado: Comparison of exercise and ajmaline tests with electrophysiologic study in the Wolff-Parkinson-White syndrome. Am J Cardiol 57:782-786, 1986.
29. S. Abboud, B. Belhassen, H.I. Miller, D. Sadeh, S. Laniado: High frequency electrocardiography using an advanced method of signal averaging for non-invasive detection of coronary artery disease in patients with normal conventional electrocardiogram. J Electrocardiology 19:371-380, 1986.
30. B. Belhassen, H.I. Miller, E. Geller, S. Laniado: Transcatheter electrical shock ablation of ventricular tachycardia. J Am Coll Cardiol 7:1347-1355, 1986.
31. B. Shargorodsky, S. Braun, B. Belhassen, S. Laniado: Antiarrhythmic and haemodynamic effects of tiapamil, a new calcium antagonist, during coronary artery occlusion and reperfusion in dogs. Cardiovasc Res 20:652-657, 1986.
32. B. Belhassen, R. Ilia, A.M. Greenspan, L.N. Horowitz: Autonomic modulation of aminophylline influence on the electrophysiological effects of adenosine and adenosine triphosphate in the canine heart. Cardiovasc Res 21:151-160, 1987.
33. B. Belhassen, I. Shapira, D. Shoshani, A. Paredes, H.I. Miller, S. Laniado: Idiopathic ventricular fibrillation: inducibility and beneficial effects of class I antiarrhythmic agents. Circulation 75:809-816, 1987.
34. B. Belhassen, A. Glick, S. Laniado: Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia. Circulation 77:795-805, 1988.
35. M. Eldar, B. Belhassen, H. Hod, C. Schuger, M. Scheinman: Exercise-induced double (atrial and ventricular) tachycardia: a report of three cases. J Am Coll Cardiol 14:1376-1381, 1989
36. B. Belhassen, I. Shapira, D. Sheps, S. Laniado: Programmed ventricular stimulation using up to two extrastimuli and repetition of double extrastimulation for induction of ventricular tachycardia: a new highly sensitive and specific protocol. Am J Cardiol 65:615-622, 1990
37. S. Viskin, B. Belhassen: Idiopathic ventricular fibrillation. Am Heart J 120:661-671, 1990
38. G. Yosipovitch, I. Heller, B. Belhassen: Bibliometric study of Cardiology in Israel in 1978, 1983 and 1988. Isr J Med Sci 27:234-238, 1991
39. S. Viskin, B. Belhassen, D. Sheps, S. Laniado: Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate. Am J Cardiol 70:879-885, 1992
40. S. Viskin, B. Belhassen, A. Roth, M. Reicher, M. Averbuch, D. Sheps, E. Shalabye, S. Laniado: Aminophylline for bradyasystolic cardiac arrest refractory to atropine and epinephrine. Ann Intern Med 118:279-281, 1993
41. M. Matsa, I. Cooperman, S. Viskin, A. Glick, Y. Gurevitch, V. Yakirevich, B. Belhassen: Transvenous implantable cardioverter defibrillator lead system: experience in 28 patients. J Cardiovasc Surg Torino 35:207-209, 1994
42. S. Viskin, G. Amir, S. Sanaullah, E. Lev, K. Heller, Y. Villa, Z. Zak, J. Chapman, S. Laniado, B. Belhassen: Attitudes of attending physicians to the incidental diagnosis of hypercholesterolemia in hospitalized patients. Am J Cardiol 75:511-513, 1995
43. S. Viskin, B. Belhassen: When you only live twice. N Engl J Med 332:1221-1225, 1995
44. S. Viskin, I. Kitzis, E. Lev, Z. Zak, K. Heller, Y. Villa, A. Zajarias, S. Laniado, B. Belhassen: Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. J Am Coll Cardiol 25:1327-1332, 1995
also published as:
44b. S. Viskin, Z. Zak, E. Lev, I. Kitzis, K. Heller, A. Zajarias, S. Laniado, B. Belhassen: Beta-blockers following myocardial infarction: the gap between randomized trials and clinical practice. Cardiol Rev 13:22-25, 1996
45. Y. Turgeman, K. Suleiman, L. Bloch, B. Belhassen, T. Rosenfeld: Transseptal left heart catheterization: a new application of an old invasive technique. Harefuah 129:382-384, 1995
45. י. תורג'מן, ח. סולימאן, ל. בלוך, ב. בלאסן, ט. רוזנפלד: דיקור המחיצה הבין פרוזדורית - סיכום ניסיון בין 4 שנים. הרפואה, כרך 129, עמ' 382-384, 1995.
46. S. Viskin, M. Lesh, M. Eldar, R. Fish, I. Setbon, S. Laniado, B. Belhassen. Mode of onset of malignant ventricular arrhythmias in idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol 8:1115-1120,1997
47. B. Belhassen, R. Fish, M. Glikson, A. Glick, M. Eldar, S. Laniado, S. Viskin: Noninvasive diagnosis of dual AV node physiology in patients with AV nodal reentrant tachycardia by administration of adenosine-5'-triphosphate during sinus rhythm. Circulation 98:47-53, 1998
48. B. Belhassen, S. Viskin , R. Fish, , A. Glick, M. Glikson, M. Eldar: Catheter-induced mechanical trauma of accessory pathways: incidence, predictors and clinical implications. J Am Coll Cardiol 33:767-774, 1999
49. B. Belhassen, S. Viskin, R. Fish, A. Glick, I. Setbon, M. Eldar: Effects of electrophysiologic-guided therapy with class 1A antiarrhythmic drugs on long-term outcome in patients with idiopathic ventricular fibrillation and the Brugada syndrome. J Cardiovasc Electrophysiol 10 :1301-1312, 1999
Article accompanied by an editorial comment by J. Ruskin:
Idiopathic ventricular fibrillation: is there a role for electrophysiologic-guided antiarrhythmic drug therapy?
J Cardiovasc Electrophysiol 10 :1313-1315, 1999
50. P. Dorostkar, M. Eldar, B. Belhassen, M. Scheinman : Long-term follow-up of patients with long-QT syndrome treated with B-blockers and continuous pacing. Circulation 100 :2431-2438, 1999
51. B. Belhassen, R. Fish, M. Eldar, A. Glick, M. Glikson, S. Viskin. Simplified ‘’ ATP test ‘’ for noninvasive diagnosis of dual AV nodal physiology and assessment of results of slow pathway ablation in patients with AV nodal reentry tachycardia. J Cardiovasc Electrophysiol 11 : 255-261, 2000
52. S. Viskin, R. Fish, D. Zeltser, B. Belhassen, K. Heller, D. Brosh, S. Laniado, H.V. Barron. Arrhythmias in the congenital long QT syndrome: How often is torsade de pointes pause-dependent ? Heart 83: 661-666, 2000
53. B. Belhassen, R. Fish, S. Viskin, A. Glick, M. Glikson, M. Eldar. Adenosine-5’-triphosphate test for the noninvasive diagnosis of concealed accessory pathway. J Am Coll Cardiol 36:803-810, 2000
54. S. Viskin, R. Fish, M. Eldar, D. Zeltser, M. Lesh, A. Glick, B. Belhassen. Prevalence of the Brugada sign in idiopathic ventricular fibrillation and healthy controls. Heart 84 :31-36, 2000
55. S. Viskin, R. Fish, A. Roth, P. Schwartz, B. Belhassen. QT or nor QT? N Engl J Med 343 :352-356, 2000
56. S. Viskin, R. Fish, A. Glick, M. Glikson, M. Eldar, B. Belhassen. The adenosine triphosphate test: A bedside diagnostic tool for identifying the mechanism of supraventricular tachycardia in patients with palpitations. J Am Coll Cardiol 38 :173-177, 2001
57. A. Halkin, A. Roth, I. Lurie, R. Fish, B. Belhassen, S. Viskin. Pause - dependent torsade de pointes following acute myocardial infarction : A variant of the acquired long QT syndrome. J Am Coll Cardiol 38 :1168-1174, 2001
58. E. Levy-Nissenbaum, M. Eldar, Q. Wang, H. Lahat, B. Belhassen, L. Ries, E. Friedman, E. Pras. Genetic analysis of Brugada syndrome in Israel : two novel mutations and possible genetic heterogeneity. Genetic Testing 5 ;331-334, 2001
59. Co-investigator in the MADIT II study ; A Moss, W. Zareba, W. Hall, H. Klein, D. Wilber D. Cannom, J. Daubert, S. Higgins, M. Brown, M. Andrews. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 ; 877-883, 2002.
60. Co-investigator in the ERAFT study ; Meinertz T, Lip GY, Lombardi F, Sadowski ZP, Kalsch B, Camez A, Hewkin A, Eberle S; ERAFT Investigators Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study). Am J Cardiol. 90 ; 1300-1306, 2002
61. B. Belhassen, R. Fish, S. Viskin, A. Glick, M. Glikson, M. Eldar Incidence of dual AV node physiology following termination of AV nodal reentrant tachycardia by adenosine-5'-triphosphate: A comparison with drug administration in sinus rhythm.
Indian Pacing and Electrophysiology Journal. 3: 3-9, 2003
62. S. Viskin, M. Ish-Shalom, E. Koifman, U. Rozovski, D. Zeltser, A. Glick, A. Finkelstein, A. Halkin, R. Fish, B. Belhassen. Ventricular flutter induced during lectrophysiologic studies in patients with old myocardial infarction. Clinical and electrophysiologic predictors, and prognostic significance. J Cardiovasc Electrophysiol 14 : 913-919, 2003.
63. I. Topilski, A. Glick. B. Belhassen. Idiopathic left ventricular tachycardia with a right bundle branch block morphology and left axis deviation (« Belhassen type ») : Results of radiofrequency ablation in 18 patients. IMAJ 6 : 195-200, 2004
Article accompanied by an editorial comment by M. Eldar. A reentry story. IMAJ 6::233-234; 2004.
64. B. Belhassen, A. Glick, S. Viskin. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 110 ; 1731-1737, 2004.
65. S. Viskin , D. Zeltser, M. Ish-Shalom, A. Katz, M. Glikson, D. Justo, D. Tekes-Manova, B. Belhassen. Is idiopathic ventricular fibrillation a short QT syndrome? Comparison of QT intervals of patients with idiopathic ventricular fibrillation and healthy controls Heart Rhythm 1 : 587-591, 2004
66. S. Viskin, R. Rosso, O. Rogowski, B. Belhassen. The « short-coupled » variant of right ventricular outflow ventricular tachycardia. a not-so-benign form of benign entricular tachycardia? J Cardiovasc Electrophysiol 16 ; 912-916, 2005
67. S. Viskin, R. Rosso, O. Rogowski, B. Belhassen, A. Levitas, A. Wagshal, A. Katz, D. Fourey, D. Zeltser, U. Rogowski, A. Olivia, G Pollevick, C. Antzelevitch, U Rozovski. Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT responses in patients with long QT syndrome. A bedside test for diagnosing long QT syndrome. Eur Heart J 2005, August 16 (epub ahead of print)
68. I. Topilski, A. Glick, S. Viskin, B. Belhassen. Frequency of spontaneous and inducible atrioventricular nodal reentry tachycardia in patients with idiopathic outflow tract ventricular arrhythmias. PACE 29 : 21-28, 2006
69. I. Topilski, O. Rogowski, A. Glick, S. Viskin, M. Eldar, B. Belhassen. Radiofrequency ablation of atrioventricular nodal reentrant tachycardia: a 14-year experience at the Tel-Aviv medical center in 901 patients. IMAJ 2006; 8: 455-459.
Article accompanied by an editorial comment by Mazur A and Strasberg B. Radiofrequency catheter ablation of atrioventricular nodal reentrant tachycardia: does the number of catheters matter? IMAJ 2006; 8: 497-498
70. I. Topilski, O. Rogowski, R. Rosso, D. Justo, Y. Copperman, M. Glikson, B. Belhassen. M. Hochenberg, S. Viskin. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias. J Am Coll Cardiol 2007: 49: 320-328
71. B. Belhassen, O. Rogowski, A. Glick, S. Viskin, M. Ilan, R. Rosso, M. Eldar.Radiofrequency ablation of accessory pathways: a 14-year experience at the Tel-Aviv medical center in 508 patients. IMAJ 2007: 9: 265-270.
72. I. Topilski, O. Rogowski, A. Glick, S. Viskin, M. Eldar, B. Belhassen Catheter-induced mechanical trauma to fast and slow pathways during radiofrequency ablation of atrioventricular nodal reentry tachycardia PACE 2007; 10:1233-1241.
73. Rosso R, Kalman JM, Rogowski O, Diamant S, Birger A, Biner S, Belhassen B, Viskin S.. Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2007; 4:1149-1154.
.
74. R. Rosso, A. Glick, M. Glikson, A. Wagshal, M. Swissa, S.. Rosenhek, I. Shetboun, V. Khalamizer, T. Fuchs, M. Boulos, M. Geist, B.Strasberg, M. Ilan, B. Belhassen.
Outcome after Implantation of ICD in patients with Brugada syndrome: a Multicenter Israeli Study (ISRABRU). On behalf of the Israeli Working Group on Cardiac Pacing and Electrophysiology. IMAJ 2008; 10: 435-439
Article accompanied by an editorial comment by Nof E. and Antzelevitch C. Risk stratification of Brugada syndrome revisited. IMAJ 2006; 8: 497-498
75. Collaborator of DEFINITE study. Albert CM, Quigg R, Saba S, Estes NA 3rd, Shaechter A, Subacius H, Howard A, Levine J, Kadish A; DEFINITE Investigators. Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic ardiomyopathy. Am Heart J. 2008; 156:367-372.
76. Rosso R, Kogan E, Belhassen B, Rozovski U, Scheinman MM, Zeltser D, Halkin A, Steinvil A, Heller K, Glikson M, Katz A, Viskin S. J-Point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. J Am Coll Cardiol 2008; 52:1231-1238.
77. Belhassen B, Glick A, Viskin S. Excellent long-term reproductibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome. PACE 2009; 32:294-301.
78. Viskin S, Wilde AA, Tan HL, Antzelevitch C, Shimizu W, Belhassen B. Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry.
Heart Rhythm 2009;6:401-404.
79. Belhassen B, Ohayon-Tsioni T, Glick A, Viskin S. An "aggressive" protocol of programmed ventricular stimulation for selecting post-myocardial infarction patients with a low ejection fraction who may not require implantation of an automatic defibrillator. IMAJ 2009; 11:520-528.
Article accompanied by an editorial comment by Haim M and Strasberg B: Programmed ventricular stimulation: how long (with the coupling interval) and aggressive (with the protocol) should we go? No easy answers. IMAJ 2009; 11:552-554.
80. Viskin S, Postema PG, Bhuiyan ZA, Rosso R, Kalman JM, Vohra JK, Guevara-Valdivia ME, Marquez MF, Kogan E, Belhassen B, Glikson M, Strasberg B, Antzelevitch C, Wilde AA. The response of the QT interval to the brief tachycardia provoked by standing a bedside test for diagnosing long qt syndrome. . J. Am Coll Cardiol. 2010; 55:1955-1961
81. Belhassen B, Glick A, Rosso R, Michowitz Y, Viskin S. Atrioventricular block during radiofrequency catheter ablation of atrial flutter: Incidence, mechanism and clinical Implications. Europace 2011; 13:1009-1014
82. Birati E, Belhassen B, Bardai A, Wilde A, Viskin S. The site of origin of torsade de pointes. Heart 2011; 97: 1650-1654.
83. Nof E, Belhassen B*, Arad M, Bhuiyan Z, Antzelevitch C, Rosso R, Fogelman R, Luria D, Eli-Ani D, Mannens M, Viskin S, Eldar M, Wilde A, Glikson M. Post-pacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene (RyR2). Heart Rhythm 2011; 8: 1546-1552.; co-first author.
Article accompanied by an editorial comment by Schimpf and Borggrefe: From ECG to mutation: Programmed ventricular stimulation providing a link to genetics of cardiac channelopathies. Heart Rhythm 2011; 8: 1553-1554.
84. Rosso R, Glikson E, Belhassen B, Katz A, Halkin A, Steinvil A, Viskin S. Distinguishing "benign" from "malignant early repolarization". The value of the ST-segment morphology. Heart Rhythm. 2012;9:225-229.
85. Itzhaki I, Maizels L, Huber I, Gepstein A, Arbel G, Caspi O, Miller L, Belhassen B, Nof E, Glikson M, Gepstein LModeling of Catecholaminergic Polymorphic Ventricular Tachycardia With Patient-Specific Human-Induced Pluripotent Stem Cells. J Am Coll Cardiol. 2012; 60:990-1000.
86. Birati EY, Eldar M, Belhassen B. Gender differences in accessory connections location: an Israeli study J Interv Card Electrophysiol. 2012; 34:227-229.
